Stock Analysis
- United States
- /
- Personal Products
- /
- NYSE:NUS
The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%
To the annoyance of some shareholders, Nu Skin Enterprises, Inc. (NYSE:NUS) shares are down a considerable 27% in the last month, which continues a horrid run for the company. The recent drop completes a disastrous twelve months for shareholders, who are sitting on a 67% loss during that time.
Following the heavy fall in price, Nu Skin Enterprises may be sending buy signals at present with its price-to-sales (or "P/S") ratio of 0.2x, considering almost half of all companies in the Personal Products industry in the United States have P/S ratios greater than 1.1x and even P/S higher than 4x aren't out of the ordinary. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.
View our latest analysis for Nu Skin Enterprises
How Nu Skin Enterprises Has Been Performing
While the industry has experienced revenue growth lately, Nu Skin Enterprises' revenue has gone into reverse gear, which is not great. Perhaps the P/S remains low as investors think the prospects of strong revenue growth aren't on the horizon. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Nu Skin Enterprises.Do Revenue Forecasts Match The Low P/S Ratio?
Nu Skin Enterprises' P/S ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the industry.
In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 9.7%. As a result, revenue from three years ago have also fallen 35% overall. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.
Turning to the outlook, the next year should bring diminished returns, with revenue decreasing 3.6% as estimated by the three analysts watching the company. That's not great when the rest of the industry is expected to grow by 4.3%.
With this in consideration, we find it intriguing that Nu Skin Enterprises' P/S is closely matching its industry peers. However, shrinking revenues are unlikely to lead to a stable P/S over the longer term. There's potential for the P/S to fall to even lower levels if the company doesn't improve its top-line growth.
The Final Word
Nu Skin Enterprises' recently weak share price has pulled its P/S back below other Personal Products companies. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.
It's clear to see that Nu Skin Enterprises maintains its low P/S on the weakness of its forecast for sliding revenue, as expected. As other companies in the industry are forecasting revenue growth, Nu Skin Enterprises' poor outlook justifies its low P/S ratio. Unless there's material change, it's hard to envision a situation where the stock price will rise drastically.
You always need to take note of risks, for example - Nu Skin Enterprises has 1 warning sign we think you should be aware of.
If you're unsure about the strength of Nu Skin Enterprises' business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.
Valuation is complex, but we're here to simplify it.
Discover if Nu Skin Enterprises might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:NUS
Nu Skin Enterprises
Engages in the development and distribution of various beauty and wellness products worldwide.